SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva
ABRYSVO met its trial primary endpoints in adults aged 18 to 59 with an increased respiratory syncytial virus (RSV) disease risk.
The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of June 21, 2024
Christoph Funke's extensive career includes leadership roles at organizations such as Fresenius Kabi and Strides Pharma Science
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
The Convocation ceremony was organized for students skilled and certified in Ayush
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
Subscribe To Our Newsletter & Stay Updated
